From: Evaluation of a new foetal shielding device for pregnant brain tumour patients
Part A (%) | Part B (%) | Part C (%) | Parts A + B (%) | Parts A + C (%) | Parts B + C (%) | Parts A + B + C (%) | |
---|---|---|---|---|---|---|---|
VMAT | |||||||
6 MV | 17.92 | 20.75 | 23.58 | 26.42 | 29.25 | 31.13 | 36.79 |
6 MV FFF | 21.05 | 22.11 | 23.16 | 28.42 | 30.53 | 31.58 | 35.79 |
IMRT | |||||||
6 MV | 21.50 | 26.41 | 15.37 | 31.31 | 22.73 | 22.73 | 34.99 |
6 MV FFF | 22.22 | 22.22 | 13.58 | 25.93 | 25.93 | 20.99 | 33.77 |